Mar Jimenez de la Pena | Medicine and Health Sciences | Medical Hypothesis Award

Published on by Research Hypothesis

Assoc. Prof. Dr. Mar Jimenez de la Pena | Medicine and Health Sciences | Medical Hypothesis Award

Assoc. Prof. Dr. Mar Jimenez de la Pena | Medicine and Health Sciences | Medical Hypothesis Award | Radiologist | University Hospital Quironsalud Madrid | Spain 

Assoc. Prof. Dr. Mar Jimenez de la Pena is a highly accomplished radiologist and academician with a distinguished career devoted to advancing diagnostic imaging, neuroimaging, and translational radiology. She completed her Licentiate in Medicine and Surgery at the Universidad Complutense de Madrid and specialized in Radiodiagnosis at Hospital 12 de Octubre in Madrid, establishing a robust clinical and scientific foundation. Currently serving as the Associate Head of Diagnostic Imaging at Hospital Universitario QuirónSalud Madrid, she also contributes as a Professor of Medicine at the Universidad Europea de Madrid, where she mentors medical students and radiology residents. Her professional experience spans more than two decades, encompassing academic instruction, clinical excellence, and leadership in medical imaging. Assoc. Prof. Dr. Mar Jimenez de la Pena has been actively engaged in national and international research collaborations, focusing on the application of advanced MRI techniques in neurological disorders, pediatric neuroimaging, and genetic syndromes. Her research interests center on neurodevelopmental disorders, brain perfusion analysis, and the application of artificial intelligence in MRI interpretation. She has demonstrated outstanding research skills in multimodal MRI data acquisition, neuroimage analysis, and clinical study design. Her work has been published in top-tier journals such as Frontiers in Neuroscience, Neuroradiology, European Journal of Medical Genetics, and American Journal of Medical Genetics Part A, significantly contributing to the understanding of complex neuroimaging patterns and clinical correlations. With over 40 peer-reviewed articles, including 33 international papers, and multiple book chapters, she has established a strong academic footprint. Assoc. Prof. Dr. Mar Jimenez de la Pena has received over 30 prestigious awards, including 29 honors from the Spanish Society of Radiology (SERAM), recognition from the Spanish Society of Neurosurgery (SENR), and an American Society of Radiology Award for her scientific presentations. Her memberships in SERAM, SENR, and ESR, alongside her role as a reviewer for Radiología, underscore her professional dedication to the advancement of radiological science. A visionary researcher and educator, she continues to contribute to training programs for medical imaging professionals, fostering innovation and excellence in radiological education. In conclusion, Assoc. Prof. Dr. Mar Jimenez de la Pena exemplifies a perfect blend of clinical expertise, academic leadership, and research innovation, making her a highly deserving candidate for international recognition in medical imaging and radiological research. Her continued contributions promise to shape the future of neuroimaging and radiodiagnostic excellence globally.

Profile: ORCID

Featured Publications 

  1. Jimenez de la Pena, M. (2023). Tatton‐Brown–Rahman syndrome: Novel pathogenic variants and new neuroimaging findings. American Journal of Medical Genetics Part A. Citations: 12

  2. Jimenez de la Pena, M. (2023). White-matter lesions and cortical cerebral blood flow evaluation by 3D arterial spin-labeled perfusion MRI in asymptomatic divers: Correlation with patent foramen ovale occurrence. Journal of Clinical Medicine. Citations: 18

  3. Jimenez de la Pena, M. (2022). Development of a super-resolution scheme for pediatric magnetic resonance brain imaging through convolutional neural networks. Frontiers in Neuroscience. Citations: 25

  4. Jimenez de la Pena, M. (2022). Mutations in the COL18A1 gene associated with Knobloch syndrome and structural brain anomalies: A novel case report and literature review of neuroimaging findings. Neurocase. Citations: 9

  5. Jimenez de la Pena, M. (2021). Neuroimaging findings in patients with EBF3 mutations: Report of two cases. Molecular Syndromology. Citations: 7

  6. Jimenez de la Pena, M. (2021). Abnormal frontal gyrification pattern and uncinate development in patients with KBG syndrome caused by ANKRD11 aberrations. European Journal of Paediatric Neurology. Citations: 15

  7. Jimenez de la Pena, M. (2020). Automatic identification of atypical clinical fMRI results. Neuroradiology. Citations: 22

 

Yun-Bae Kim | Medicine and Health Sciences | Best Researcher Award

Published on by Research Hypothesis

Prof. Yun-Bae Kim | Medicine and Health Sciences | Best Researcher Award

Prof. Yun-Bae Kim | Medicine and Health Sciences | Best Researcher Award | Professor | Chungbuk National University | South Korea

Prof. Yun-Bae Kim, a distinguished professor at the Department of Toxicology, College of Veterinary Medicine, Chungbuk National University, Republic of Korea, is an eminent scholar in the fields of toxicology, neurobiology, and regenerative medicine. Holding both a Doctor of Veterinary Medicine (D.V.M.) and a Ph.D. in Veterinary Medicine from Seoul National University, Prof. Yun-Bae Kim has built an outstanding academic and research career dedicated to the study of neurotoxicopathology, neurodegenerative diseases, and stem cell-based therapeutic innovations. His research primarily explores the toxicopathologic mechanisms of chemicals, brain aging, and the development of gene-modified stem cells to treat degenerative diseases such as Alzheimer’s disease, Parkinson’s disease, and cerebral palsy. With over 370 peer-reviewed publications and patents indexed in Scopus, PubMed, and other global databases, Prof. Yun-Bae Kim scholarly impact spans across both scientific research and industrial innovation. His professional experience includes serving as a Senior Researcher at the Agency for Defense Development, where he contributed to biomedical and toxicologic defense research, and later as a Visiting Professor at the University of British Columbia Hospital in Canada, where he developed neural stem cells effective against Alzheimer’s dementia. Prof. Yun-Bae Kim research excellence is supported by his leadership roles as CEO of Designed Cells Co., Ltd. in Korea, Vice-Chair of Qingdao Sinder Designed Stem Cells Co., Ltd. in China, Co-Chair of Designed Cells Europe D.O.O. in Croatia, and Chief Scientific Officer of ThanEver Inc. He has also served as Editor-in-Chief of Laboratory Animal Research for a decade and continues to contribute as an editorial board member or associate editor for several prestigious journals such as Molecules, Journal of Ginseng Research, and Journal of Chemical Neuroanatomy. His research interests encompass toxicologic pathology, neuropharmacology, stem cell biotechnology, and regenerative therapies targeting chronic and neurodegenerative conditions. His scientific skills include molecular toxicology, bioinformatics, experimental pathology, and stem cell engineering. Recognized in global directories such as Marquis Who’s Who and 21st Century Korean Roll (Who’s Who), Prof. Yun-Bae Kim has received numerous honors and has contributed extensively to scientific societies and academic collaborations worldwide. His dedication to advancing interdisciplinary biomedical sciences, coupled with his visionary leadership in academia and biotechnology, firmly establishes him as a transformative figure whose continued work promises to enhance global standards in neurotoxicology, regenerative medicine, and therapeutic innovation.

Profile:  Google scholar | Scopus

Featured Publications

  1. Kim, Y.-B., et al. (2024). BVN008, Diphtheria-tetanus-acellular pertussis combined vaccine has no effects on fertility and prenatal and postnatal developmental toxicity in female Sprague-Dawley rats. Reproductive Toxicology, 126, 108587. (1 citation)

  2. Kim, Y.-B., et al. (2024). The Role of Prolactin in Amniotic Membrane Regeneration: Therapeutic Potential for Premature Rupture of Membranes. Endocrinology.

  3. Kim, Y.-B., et al. (2023). Repeated Intravenous Administration of Human Neural Stem Cells Producing Choline Acetyltransferase Exerts Anti-Aging Effects in Male F344 Rats. Cells, 12(5). (2 citations)

  4. Kim, Y.-B., et al. (2023). An Exosome-Rich Conditioned Medium from Human Amniotic Membrane Stem Cells Facilitates Wound Healing via Increased Reepithelization, Collagen Synthesis, and Angiogenesis. Cells, 12(4). (12 citations)

  5. Kim, Y.-B., et al. (2023). Preventive Effects of Exosome-Rich Conditioned Medium From Amniotic Membrane-Derived Mesenchymal Stem Cells for Diabetic Retinopathy in Rats. Translational Vision Science & Technology, 12(6). (10 citations)

  6. Kim, Y.-B., et al. (2023). Effectiveness of Combinational Treatments for Alzheimer’s Disease with Human Neural Stem Cells and Microglial Cells Over-Expressing Functional Genes. International Journal of Molecular Sciences, 24(9). (6 citations)

  7. Kim, Y.-B., et al. (2023). Antioxidative and Anti-Inflammatory Activities of Rosebud Extracts of Newly Crossbred Roses. Nutrients, 15(10). (3 citations).

 

Tianhui Yuan | Medicine and Health Sciences | Best Researcher Award

Published on by Research Hypothesis

Prof. Dr. Tianhui Yuan | Medicine and Health Sciences | Best Researcher Award

Associate Director | The First Affiliated Hospital of Guangzhou University of Medicine | China

Prof. Dr. Tianhui Yuan is a distinguished physician-scientist whose educational journey culminated in the M.D. and a Ph.D. in integrated medicine and cardiovascular science (with doctoral training at a leading university), and she currently serves as Chief Physician, Doctoral Supervisor, and Associate Director of her department while also holding a Visiting Scholar appointment in the United States. Over her career, she has held progressive roles in clinical practice, laboratory research, and academic leadership in integrative Chinese and Western medicine. Her professional experience spans directing clinical care units in cardiovascular medicine, mentoring doctoral and postdoctoral researchers, coordinating international research collaborations, and representing her institution in health policy and traditional medicine networks. Her research interests lie at the interface between traditional Chinese medicine and modern cardiovascular disease therapy, particularly focusing on mechanisms and therapeutic strategies for heart failure, cardiomyopathy, coronary artery disease, hypertension, arrhythmia, hyperlipidemia, and insomnia. She is skilled in experimental cardiovascular physiology, molecular biology, signaling pathway analysis, preclinical animal models, translational interventions, and clinical guideline development. She has made significant scholarly contributions: she has authored 15 documents, received 154 Citations, and holds an h-index of 7, reflecting a growing impact. Among her honors and awards, she has been selected for the Guangdong Provincial Health Commission’s “Guangdong Special Support Program” and the “Youth Talent Support Program,” and she holds recognition as a young academic leader at her university; she also serves on multiple national and international professional committees and has contributed to guideline development, patent filing (2 invention patents), software intellectual property (1 software copyright), and the authorship of 9 books. Through mentorship she has guided student teams to high distinction in innovation competitions and has been invited as a keynote speaker at major conferences like the ESC Heart Failure Congress and the International Heart Congress. Given her solid educational foundation, extensive clinical and research experience, integrative medicine focus, leadership roles, and peer-recognized contributions, Prof. Dr. Tianhui Yuan is exceptionally well positioned to advance her field further, strengthen international collaborations, expand high-impact publication outputs, and mentor the next generation of integrative cardiovascular researchers.

Profile: Scopus

Featured Publications

  1. Ma, X., … Yuan, T. (2023). Regulation of phospholipid peroxidation signaling by a traditional Chinese medicine formula to prevent myocardial ischemia. Journal Name.

  2. Dong, X., Han, X., Zhang, X., … Yuan, T. (2022). A simplified herbal formula improves cardiac function and reduces inflammation in mice through the TLR-mediated NF-κB signaling pathway. Journal Name.

  3. Yang, Z., Xian, S., Yuan, T. (2020). Dexmedetomidine-mediated regulation of miR-17-3p in H9C2 cells after hypoxia/reoxygenation injury. Journal Name.

  4. Yuan, T., Chen, Y., Zhou, X., … (2019). Effectiveness and safety of Danshen injection on heart failure: protocol for a systematic review and meta-analysis. Journal Name.

  5. Wang, L., Gao, M., Chen, J., … (2015). Resveratrol ameliorates pressure overload-induced cardiac dysfunction and attenuates autophagy in rats. Journal Name.